ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!
Search for

UniProtKB/Swiss-Prot entry Q9GZV9


[Entry info] [Name and origin] [References] [Comments] [Cross-references] [Keywords] [Features] [Sequence] [Tools]

Note: most headings are clickable, even if they don't appear as links. They link to the user manual or other documents.
Entry information
Entry name FGF23_HUMAN
Primary accession number Q9GZV9
Secondary accession number Q4V758
Integrated into Swiss-Prot on April 27, 2001
Sequence was last modified on March 1, 2001 (Sequence version 1)
Annotations were last modified on    June 16, 2009 (Entry version 95)
Name and origin of the protein
Protein name Fibroblast growth factor 23 [Precursor]
Synonyms FGF-23
Tumor-derived hypophosphatemia-inducing factor
Phosphatonin
Contains Fibroblast growth factor 23 N-terminal peptide
Fibroblast growth factor 23 C-terminal peptide
Gene name
Name: FGF23
Synonyms: HYPF
ORFNames: UNQ3027/PRO9828
From
Homo sapiens (Human) [TaxID: 9606] 
Taxonomy Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo.
Protein existence 1: Evidence at protein level;
References
[1]
NUCLEOTIDE SEQUENCE [MRNA].
DOI=10.1006/bbrc.2000.3696; PubMed=11032749 [NCBI, ExPASy, EBI, Israel, Japan]
Yamashita T., Yoshioka M., Itoh N.;
"Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain.";
Biochem. Biophys. Res. Commun. 277:494-498(2000).
[2]
NUCLEOTIDE SEQUENCE [MRNA], VARIANTS ADHR GLN-176; GLN-179 AND TRP-179, AND VARIANT MET-239.
DOI=10.1038/81664; PubMed=11062477 [NCBI, ExPASy, EBI, Israel, Japan]
White K.E., Evans W.E., O'Riordan J.L.H., Speer M.C., Econs M.J., Lorenz-Depiereux B., Grabowski M., Meitinger T., Strom T.M.;
"Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23.";
Nat. Genet. 26:345-348(2000).
[3]
NUCLEOTIDE SEQUENCE [MRNA].
DOI=10.1073/pnas.101545198; PubMed=11344269 [NCBI, ExPASy, EBI, Israel, Japan]
Shimada T., Mizutani S., Muto T., Yoneya T., Hino R., Takeda S., Takeuchi Y., Fujita T., Fukumoto S., Yamashita T.;
"Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia.";
Proc. Natl. Acad. Sci. U.S.A. 98:6500-6505(2001).
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
DOI=10.1101/gr.1293003; PubMed=12975309 [NCBI, ExPASy, EBI, Israel, Japan]
Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J., Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P., Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
"The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.";
Genome Res. 13:2265-2270(2003).
[5]
NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS SER-195 AND MET-239.
NIEHS SNPs program;
Submitted (MAR-2004) to the EMBL/GenBank/DDBJ databases.
[6]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[7]
PROTEIN SEQUENCE OF 25-39.
DOI=10.1110/ps.04682504; PubMed=15340161 [NCBI, ExPASy, EBI, Israel, Japan]
Zhang Z., Henzel W.J.;
"Signal peptide prediction based on analysis of experimentally verified cleavage sites.";
Protein Sci. 13:2819-2824(2004).
[8]
PROCESSING.
DOI=10.1210/jc.86.2.497; PubMed=11157998 [NCBI, ExPASy, EBI, Israel, Japan]
White K.E., Jonsson K.B., Carn G., Hampson G., Spector T.D., Mannstadt M., Lorenz-Depiereux B., Miyauchi A., Yang I.M., Ljunggren O., Meitinger T., Strom T.M., Jueppner H., Econs M.J.;
"The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting.";
J. Clin. Endocrinol. Metab. 86:497-500(2001).
[9]
PROCESSING.
DOI=10.1210/en.143.8.3179; PubMed=12130585 [NCBI, ExPASy, EBI, Israel, Japan]
Shimada T., Muto T., Urakawa I., Yoneya T., Yamazaki Y., Okawa K., Takeuchi Y., Fujita T., Fukumoto S., Yamashita T.;
"Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo.";
Endocrinology 143:3179-3182(2002).
[10]
PROCESSING BY PROPROTEIN CONVERTASES.
DOI=10.1016/j.bone.2004.04.002; PubMed=15268897 [NCBI, ExPASy, EBI, Israel, Japan]
Benet-Pages A., Lorenz-Depiereux B., Zischka H., White K.E., Econs M.J., Strom T.M.;
"FGF23 is processed by proprotein convertases but not by PHEX.";
Bone 35:455-462(2004).
[11]
X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 25-179.
DOI=10.1128/MCB.02249-06; PubMed=17339340 [NCBI, ExPASy, EBI, Israel, Japan]
Goetz R., Beenken A., Ibrahimi O.A., Kalinina J., Olsen S.K., Eliseenkova A.V., Xu C., Neubert T.A., Zhang F., Linhardt R.J., Yu X., White K.E., Inagaki T., Kliewer S.A., Yamamoto M., Kurosu H., Ogawa Y., Kuro-o M., Lanske B., Razzaque M.S., Mohammadi M.;
"Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members.";
Mol. Cell. Biol. 27:3417-3428(2007).
[12]
VARIANT HFTC GLY-71.
DOI=10.1093/hmg/ddi034; PubMed=15590700 [NCBI, ExPASy, EBI, Israel, Japan]
Benet-Pages A., Orlik P., Strom T.M., Lorenz-Depiereux B.;
"An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia.";
Hum. Mol. Genet. 14:385-390(2005).
Comments
Copyright
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms. Distributed under the Creative Commons Attribution-NoDerivs License.
Cross-references
Sequence databases
EMBL
AB037973; BAB13477.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AF263537; AAG09917.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AB047858; BAB55889.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AY358323; AAQ88689.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AY566236; AAS59157.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
BC069333; AAH69333.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
BC096713; AAH96713.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
BC098147; AAH98147.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
BC098252; AAH98252.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
IPI IPI00026407; -.
RefSeq NP_065689.1; -.
UniGene Hs.287370
3D structure databases
PDB
2P39; X-ray; 1.50 A; A=25-179.[ExPASy / RCSB / EBI]
PDBsum 2P39; -.
ModBase Q9GZV9.
Enzyme and pathway databases
Pathway_Interaction_DB fgf_pathway; FGF signaling pathway.
Reactome REACT_9470; Signaling by FGFR.
Organism-specific databases
GeneCards GC12M004347; -.
H-InvDB HIX0036668; -.
HGNC HGNC:3680; FGF23.
GenAtlas FGF23.
MIM 193100; phenotype. [NCBI / EBI]
211900; phenotype. [NCBI / EBI]
605380; gene. [NCBI / EBI]
Orphanet 53715; Calcinosis, tumoral.
437; Vitamin D resistant rickets.
PharmGKB PA28119; -.
Gene expression databases
ArrayExpress Q9GZV9; -.
Bgee Q9GZV9; -.
CleanEx HS_FGF23; -.
GermOnline ENSG00000118972; Homo sapiens.
Ontologies
GO
GO:0005615; Cellular component: extracellular space (non-traceable author statement from UniProtKB).
GO:0008083; Molecular function: growth factor activity (inferred from electronic annotation from UniProtKB-KW).
GO:0030154; Biological process: cell differentiation (non-traceable author statement from UniProtKB).
GO:0008543; Biological process: fibroblast growth factor receptor signaling pathway (inferred from experiment from Reactome).
QuickGo view.
Family and domain databases
InterPro IPR002348; IL1_HBGF.
Graphical view of domain structure.
PANTHER PTHR11486; IL1_HBGF; 1.
Pfam PF00167; FGF; 1.
Pfam graphical view of domain structure.
PRINTS PR00262; IL1HBGF.
ProDom PD000831; IL1_HBGF; 1.
[Domain structure / List of seq. sharing at least 1 domain]
SMART SM00442; FGF; 1.
SMART graphical view of domain structure.
PROSITE PS00247; HBGF_FGF; FALSE_NEG.
Proteomic databases
PRIDE Q9GZV9; -.
Genome annotation databases
Ensembl ENSG00000118972; Homo sapiens. [Contig view]
GeneID 8074; -.
KEGG hsa:8074; -.
NMPDR fig|9606.3.peg.6984; -.
Phylogenomic databases
HOGENOM Q9GZV9; -.
HOVERGEN Q9GZV9; -.
OMA Q9GZV9; ASDPLGV.
Other
NextBio 30678; -.
SOURCE FGF23; Homo sapiens.
ProtoNet Q9GZV9.
UniRef View cluster of proteins with at least 50% / 90% / 100% identity.
Keywords
3D-structure; Direct protein sequencing; Disease mutation; Disulfide bond; Growth factor; Polymorphism; Secreted; Signal.
Features
SEVIEWER logo Feature table viewer FT aligner logo Feature aligner
KeyFrom   To Length Description FTId
SIGNAL   1    24  24      
CHAIN   25   251  227     Fibroblast growth factor 23. PRO_0000008998
CHAIN   25   179  155     Fibroblast growth factor 23 N-terminal peptide. PRO_0000352875
CHAIN   180   251  72     Fibroblast growth factor 23 C-terminal peptide. PRO_0000352876
SITE   179   180  2     Cleavage; by proprotein convertases. 
DISULFID   95   113         
VARIANT   71    71  1     S -> G (in HFTC; only the C-terminal fragment is secreted, whereas the intact protein is retained in the Golgi complex). VAR_023831 
VARIANT   176   176  1     R -> Q (in ADHR). VAR_010717 
VARIANT   179   179  1     R -> Q (in ADHR; C-terminal processing is abolished). VAR_010719 
VARIANT   179   179  1     R -> W (in ADHR; C-terminal processing is abolished). VAR_010718 
VARIANT   195   195  1     P -> S (in dbSNP:rs13312793 [NCBI]). VAR_018887 
VARIANT   239   239  1     T -> M (in dbSNP:rs7955866 [NCBI]). VAR_010720 
STRAND   40    43  4      
STRAND   47    49  3      
STRAND   52    55  4      
STRAND   61    66  6      
TURN   69    71  3      
STRAND   73    77  5      
HELIX   79    81  3      
STRAND   82    87  6      
TURN   88    91  4      
STRAND   92    96  5      
STRAND   102   107  6      
TURN   110   112  3      
STRAND   115   119  5      
STRAND   125   128  4      
TURN   130   132  3      
STRAND   138   140  3      
HELIX   153   155  3      
STRAND   157   161  5      
HELIX   166   168  3      
Sequence information
Length: 251 AA [This is the length of the unprocessed precursor] Molecular weight: 27954 Da [This is the MW of the unprocessed precursor] CRC64: 6093BD0CC50C2489 [This is a checksum on the sequence]
        10         20         30         40         50         60 
MLGARLRLWV CALCSVCSMS VLRAYPNASP LLGSSWGGLI HLYTATARNS YHLQIHKNGH 

        70         80         90        100        110        120 
VDGAPHQTIY SALMIRSEDA GFVVITGVMS RRYLCMDFRG NIFGSHYFDP ENCRFQHQTL 

       130        140        150        160        170        180 
ENGYDVYHSP QYHFLVSLGR AKRAFLPGMN PPPYSQFLSR RNEIPLIHFN TPIPRRHTRS 

       190        200        210        220        230        240 
AEDDSERDPL NVLKPRARMT PAPASCSQEL PSAEDNSPMA SDPLGVVRGG RVNTHAGGTG 

       250 
PEGCRPFAKF I 

Q9GZV9 in FASTA format

View entry in raw text format (no links)
Report form for errors/updates in this UniProtKB/Swiss-Prot entry

BLAST logo BLAST submission on ExPASy/SIB
or at NCBI (USA)
Tools Sequence analysis tools: ProtParam, ProtScale, Compute pI/Mw, PeptideMass, PeptideCutter, Dotlet (Java)
PROSITE logo ScanProsite, MotifScan SWISS-MODEL Submit a homology modeling request to SWISS-MODEL
NPSA logo NPSA Sequence analysis tools

ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
 Hosted by ca flag CBR Canada Mirror sites: Australia  Brazil  China  Korea  Switzerland
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!